Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian Population

Table 1

Level of GAD65A in autoantibody-positive diabetic patients.

	GAD65A; (IU/ml) in LADA; ()	GAD65A (IU/ml) in; Ab^+T2D ()
М (SD)	192.94 (78.77)	109.06 (75.61)	0.014
Md	232.30	113.10
Minimum	25.80	11.80
Maximum	274.90	210.80

M: mean; SD: standard deviation; Md: median; n: number; GAD65A: antiglutamic acid decarboxylase 65 autoantibodies; LADA: latent autoimmune diabetes of the adults; Ab⁺T2D: autoantibody-positive cases in T2D group.